Background/Aims: Preserved red blood cells (RBCs) in vitro undergo a series of morphological, functional and metabolic changes during storage. RBC metabolites accumulate over time during storage, the toxicity of the supernatants of RBCs (SSRBCs) on tissue cells is largely unknown. Here, we aimed to study cardiomyocyte toxicity by supernatant of long termstored RBCs in vitro and to discover elements involved in the mechanism. Methods: Using human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) and real-time cell analyzing (RTCA), we analyzed the cardiotoxicity of d0, d14 and d35 SSRBCs. To analyze the cardiotoxicity of potassium (K) and lactic acid (LA) in SSRBCs, solutions containing the same concentrations of K and LA were respectively prepared and co-cultured with hiPS-CMs. effects of d35 K and d35 SSRBCs. Results: The beating of hiPS-CM was stopped by d14, d35 SSRBCs, or d35 K solution. Beating resumed within 48 hours in the presence of d14 SSRBC or d35 K but not d35 SSRBC; d0, d14 and d35 LA solution had no effect on beating patterns. At genes which were likely to play an important role in the cytotoxic effect. Conclusion: Our results demonstrated cardiomyocyte toxicity by long term-stored SSRBCs in vitro. Besides high K-induced cardiotoxicity, there must be other unknown components in long term-stored SSRBCs that are cytotoxic to hiPS-CMs.
Induction of Pluripotent Stem Cell-Derived Cardiomyocyte Toxicity by Supernatant of Long Term-Stored Red Blood Cells in Vitro
mortality among a general population of hospitalized patients [15] , frequency of 5 major adverse outcomes among premature low-birth-weight infants [16] , 90-day mortality among critical care patients [17] and Multiple Organ Dysfunction Score following cardiac surgery [18] . Therefore, whether the duration of RBCs storage is associated with increased risks of clinically adverse events is still unclear [19] .
In this study, we examined the cardiotoxicity induced by SSRBCs utilizing humaninduced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) to directly evaluate the cytotoxic effects of SSRBCs. The use of hiPS-CMs eliminates the inter-species difference between mice and human, and faithfully reproduces cardiac electrophysiological properties of human cardiomyocytes [20] . Unlike primary rat neonatal cardiomyocytes, the beating CMs or medium changing. Therefore, hiPS-CMs have gained wide acceptance as a biologically relevant in vitro model for drug discovery and cardiotoxicity screens [21, 22] . Compared to cytotoxicity assays on H9C2 cell line, hiPS-CMs are more sensitive for the detection of potential cardiac side effects which can be indicated by the beating patterns of CMs [23] . The real-time cell analyzing (RTCA) Cardio system is a non-invasive, impedance-based biosensor system that can monitor CMs growth and beating status simultaneously in a drug-sensitive manner [24, 25] .
In the present study, we examined the cardiotoxicity of SSRBCs on human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) which are sensitive to toxicants. The beating of hiPS-CMs was recorded in real time using the Real-Time Cell Analyzing (RTCA) assay to determine the time-dependent cardiotoxicity of long-term preserved SSRBCs. In addition, we also investigated in the mechanism of cardiotoxicity by examining the effects of potassium (K) and lactic acid (LA) in the SSRBCs, which may be the potential toxic components, and gene expression in beating arrested hiPS-CMs through mRNA microarray.
Materials and Methods

Sample collection
suspended in the additive solution NaCl-phosphate-adenine-dextrose-mannitol-citrate (MAP) in a PVC-DEHP container (NIGALE, Sichuan, China) were obtained. All RBC components were leukoreduced using according to blood bank requirements. Suspended until the cells
The medium in Cardio E-Plate was replaced with hiPS-CMs maintaining medium 4h before treatment. HiPS-CMs were treated with d0, d14, and d35 SSRBCs or maintaining medium. Positive inotropic compounds transfusion of large blood volume. This volumetric relationship is equivalent to the infusion of 2000ml suspended RBCs in a 60 kg adult, which is approximately 80 ml of blood/kg of body weight [9] .
Real-time cardiomyocytes analysis
The cardiomyocyte-based biosensor can monitor the cardiomyocyte cell index (CI) and beating status simultaneously. The device, which was placed inside the incubator, was able to switch from any wells on the differences in cell number, level of adhesion, cell morphology and viability. CI values increased gradually and consistently as cells become attached to the electrodes [27] . Beating status of CMs was described through the beating parameters beating rate (BR) and amplitude (A). The normalized cell index (NCI) was the ratio of CI at the time of interest to the CI taken prior to the treatment. The normalized beating rate (NBR) and normalized amplitude (NA) were similarly calculated. CI was recorded every 5 min, and beating status was recorded every 30 min for 48h following SSRBCs treatment.
Evaluation of the cardiotoxicity of K and LA solution
In order to determine whether K and LA in the SSRBCs have cytotoxic effects on hiPS-CMs, the process of cell culture was repeated and the premade LA solution, K solution, and mixture of K and LA solution simultaneously measured as controls.
mmuno uorescence assay
HiPS-CMs were placed on glass coverslips and treated with d35 K solution, mixed d35 SSRBCs or paraformaldehyde, and permeabilized with 0.2% Triton X-100. The cells were washed in PBS, blocked and overnight. On the IgG secondary antibody for 1 h, and the nuclei were then counterstained with DAPI (100 ng/ml) for 10 min. The images were acquired using a laser confocal microscope (Leica TCS SP5 II, Heidelberg, Germany). 
Microarray data analysis
calculate gene expression. The RMA-normalized expression values can be used for sample correlation and differential gene expression analyses. Genes were considered differentially expressed when they displayed
Reverse transcription-PCR (RT-PCR)
In d35 SSRBCs group and naive group, RT-PCR was used to validate the microarray data of differentially Quantitative real-time PCR (qPCR) was analyzed by StepOnePlus Real-time PCR System (Applied Biosystems, levels of all detected genes were normalized to ACTB.
Statistical analysis
Data were analyzed using the xCELLigence Cardio Software (Roche, Mannheim, Germany). Calculations and further analyses were performed using GraphPad Prism 5 (Graphpad Software, San Diego, CA, USA) or SPSS PASW Statistics v18.0 (Mathworks, Natick, MA, USA). The reported data were expressed as mean ± SD. Inter-group comparison was performed using one-way ANOVA or Student's t-test. p<0.05 was considered SSRBCs to the hiPS-CMs maintaining medium (17%
Results
Detection of biochemical indicators in SSRBCs
Cardiotoxicity of SSRBCs on hiPS-CMs
The cytotoxic effects of SSRBCs on hiPS-CMs were described by NCI, NA, NBR and beating pattern. a sharp fall in NCI value to 0.4, which was then maintained at a steady level of 0.5. At 48 h, there was three SSRBCs groups, but the NCI values of the three of the naive group. There were no marked changes 1C). NA and NBR values in the d14 group were close differences in NA and NBR values between the d0 group, d14 group and naive group at 48h. NA and NBR values in the d35 group at 48h were close to zero and were not analyzed. The 5 individual SSRBCs samples in each of the d14 and d35 group had certain effects on the beating patterns of hiPS-CMs. Both d14 and d35 SSRBCs treatments induced arrest in beating, only the beating patterns in the d14 group were restored group were never restored Cardiotoxicity of K and LA solution on hiPSCMs. Effect of K and LA solutions on the NCI value and beating pattern of hiPSCMs showed that the effects and d35 samples on NCI value and beating pattern were consistent with those 3A and 4A). D0, d14 and d35 LA solutions had no effects on NCI value and beating pattern of hiPS-CMs effects on NCI value and and 4). However, d35 K solution induced an arrest in hiPS-CMs beating and was restored within 48h 
Gene expression array
The correlation between the d35 K group, d35 SSRBCs group and naive group were analyzed using the principal component analysis (PCA). There was no separation between the naive and d35K samples. On the contrary, d35 SSRBCs samples segregated distinctly and 86 showed decreased expression (> 2-fold, P < 0.05) in the d35 SSRBCs group compared muscle contraction are listed in Table 4 . Results of RT-PCR show that expect ANKRD1 the expression of the other 14 genes (HBB, ABCG1, ABCA1, TRIL, SSPN, CASQ1, CNN1, NPR3, PRKAR1A, SLC25A4, XIRP2, NEXN, TRDN, ACTA1) were consistent to the microarray
Discussion
In past studies, cardiotoxicity was not easily assessed using primary neonatal anthropic factors on the counting of beating rate by naked eye under the optical microscope. Using the RTCA Cardio system, we recorded the time-response changes in NCI, NA, NBR, and beating pattern which are not obtainable by naked eyes. Time-dependent cardiotoxicity was examined in the three SSRBCs groups. As the preservation time extended, d0, d14 and d35 SSRBCs demonstrated increasing cytotoxic effects on the hiPS-CMs.
Levels of K and LA in SSRBCs increase substantially during RBC storage due to the metabolism of RBCs, K leakage from the RBCs, and RBC lysis. In our study, the level of K in MAP-suspended RBCs increased from 1.99 to 40.61 mmol/L, and the level of LA increased from 2.88 to 14.98 mmol/L from d0 to d35 of RBCs storage. Similar to our results, the level of K in d35 CPDA-1 whole blood and in d42 SAMG-suspended RBCs were 78.5 mmol/L and 45.3 mmol/L, respectively [28] . Clinical hyperkalemia resulting from RBCs transfusions has been recognized as a transfusion complication for decades. Hyperkalemia can not only lead to cardiac arrests [29] , but it also occurs frequently in hospitalized patients and is of particular concern for those who have undergone surgery, with postoperative care provided by clinicians of many disciplines [30] .
hyperkalemia can result following the infusion of a number of RBCs units, especially in infants and small children. Whether but weaker cardiotoxicity was observed after treatment at the same concentration of K d35 K stopped hiPS-CMs beating and showed a moderate decline of NCI value. Since the concentration of K in d35 SSRBCs-treated hiPS-CMs culture medium was much higher than normal human plasma K levels (3.5-5.5mmol/L), it may be the major cause of beating arrest in vitro just as shown in the d35 K group. We found that the concentration of LA in d35 SSRBCs-treated hiPS-CMs culture medium was 2.76 mmol/L, and it had no effect on hiPSCMs growth and beating pattern. SSRBCs, and found that monocyte function was suppressed after exposure to supernatants from d 30 RBCs units compared to monocytes cultured in medium alone. Similar to our mediators in stored RBCs [10] . In addition, they also showed that these immunosuppressive effects of co-incubation with packed RBCs were not related to the concentration of free transfusions [34, 35] . Here, we looked at the observational results of more heavily transfused patient populations simulating a typical blood volume of 2000 ml per 60 kg body weight. The microarray analysis indicated that there was no consistent separation within the naive and d35 K samples, but a large change in gene expression between the d35 SSRBCs and naive group. This was further evidence that d35 K was not the only cause, and there must be other components and related signaling pathways that were involved in the cardiotoxicity.
patients with K concentrations of 12.0 mmol/L have no cardiac arrest. In fact, increased K associated with RBCs transfusions may be redistributed in vivo within minutes. In study of Brown et al, increased hyperkalemia levels caused by rapid blood transfusion declined to below 5.5 mmol/L within 30 minutes. None of the patients with an elevated plasma K in vitro experiment, the purity of hiPS-CMs was 99% and above, and hence there were not enough cells available for K redistribution.
These data suggest that K in d35 SSRBCs can result in a rapid and complete, but shortterm arrest of hiPS-CMs beating, and other metabolic components of RBCs may play a role in demonstrate their mechanisms.
